DHS 75.59(21)(b)3.3. Require a patient to return all empty take-home bottles on the patient’s next day of service attendance following take-home dosing. Clinical staff shall examine the bottles to ensure that the bottles are received from the appropriate patient and in an intact state.

DHS 75.59(21)(b)4.4. The service may discontinue take-home medications for patients who fail to return empty take-home bottles in the prescribed manner. If upon review of take home medication it is determined that medication is missing and cannot reasonably be accounted for the service shall discontinue take home medication.

DHS 75.59(21)(c)(c) Counselor responsibility. If a service receives reliable information that a patient is diverting medication, the patient’s primary counselor shall immediately discuss the problem with the patient.

DHS 75.59(21)(d)(d) Revocation of take homes. Based on information provided by the patient or continuing reports of diversion, a service may revoke take-home privileges of the patient.

DHS 75.59(21)(e)(e) State revocation of take-homes. The SOTA may, based on reports of diversion, revoke take-home privileges, exceptions or exemptions granted to or by the service for all patients. If a service agency disagrees with the SOTA’s decision, it may provide additional relevant information to the SOTA, request that SOTA review the revocation decision, or file a request for review and reconsideration of the revocation decision with the Department’s Division of Care and Treatment Services.

DHS 75.59(21)(f)(f) State revocation of a services ability to grant take-homes. The SOTA may revoke the authority of an OTP to grant take-home privileges when the service cannot demonstrate that all requirements have been met in granting take-home privileges to patients. If a service agency disagrees with the SOTA’s decision, it may provide additional relevant information to the SOTA, request that SOTA review the revocation decision, or file a request for review and reconsideration of the revocation decision with the Department’s Division of Care and Treatment Services.

DHS 75.59(21)(g)(g) Loitering. An OTP shall have a written policy to discourage the congregation of patients at a location inside or outside the service facility for non-programmatic reasons, and shall post that policy in the facility.

DHS 75.59(21)(h)(h) Callbacks. The diversion control plan shall contain, at a minimum, a random call-back program with mandatory compliance that includes:

DHS 75.59(21)(h)2.2. Each patient receiving two or more take-home medications shall be called back randomly but no less frequently than on a quarterly basis.

DHS 75.59(21)(h)3.3. Upon call back a service recipient shall report to the clinic the next day within dosing hours, with all take-home medications. The quantity and integrity of packaging shall be verified for all doses. If a take-home dose shows evidence of tampering, the clinic shall impose uniform sanctions for violating take-home policies, including sanctions for a patient’s tampering with a take-home dose.

DHS 75.59(22)(a)(a) Approval of primary service. An applicant for approval to operate an OTP in Wisconsin with the intent of administering or dispensing medication for the treatment of an opioid use disorder shall submit all of the following to the SOTA:

DHS 75.59(22)(a)2.2. A copy of the request for registration with the DEA for the use of narcotic medications in the treatment of opiate addiction.

DHS 75.59(22)(a)3.3. A narrative description of the treatment services that will be provided in addition to medication.

DHS 75.59(22)(a)6.6. A copy of the policy and procedures manual for the service, detailing the operation of the service as follows:

DHS 75.59(22)(a)6.e.e. A description of the service’s use of testing or analysis to detect substances and the purposes for which the results of testing or analysis are used as well as the frequency of use.

DHS 75.59(22)(a)8.8. Documentation that the service will have ready access to a comprehensive range of medical and rehabilitative services that will be available if needed, including the name, address, and a description of each hospital, institution, clinical laboratory or other facility available to provide the necessary services.

DHS 75.59(22)(a)9.9. A list of persons working in the service who are licensed to administer or dispense narcotic drugs even if they are not responsible for administering or dispensing narcotic drugs.